528 related articles for article (PubMed ID: 20924967)
1. Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs.
Goel A; Aggarwal BB
Nutr Cancer; 2010; 62(7):919-30. PubMed ID: 20924967
[TBL] [Abstract][Full Text] [Related]
2. NTP Toxicology and Carcinogenesis Studies of Turmeric Oleoresin (CAS No. 8024-37-1) (Major Component 79%-85% Curcumin, CAS No. 458-37-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Aug; 427():1-275. PubMed ID: 12616304
[TBL] [Abstract][Full Text] [Related]
3. Anticancer potential of curcumin: preclinical and clinical studies.
Aggarwal BB; Kumar A; Bharti AC
Anticancer Res; 2003; 23(1A):363-98. PubMed ID: 12680238
[TBL] [Abstract][Full Text] [Related]
4. Curcumin and cancer: an "old-age" disease with an "age-old" solution.
Anand P; Sundaram C; Jhurani S; Kunnumakkara AB; Aggarwal BB
Cancer Lett; 2008 Aug; 267(1):133-64. PubMed ID: 18462866
[TBL] [Abstract][Full Text] [Related]
5. Curcumin as "Curecumin": from kitchen to clinic.
Goel A; Kunnumakkara AB; Aggarwal BB
Biochem Pharmacol; 2008 Feb; 75(4):787-809. PubMed ID: 17900536
[TBL] [Abstract][Full Text] [Related]
6. Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent.
López-Lázaro M
Mol Nutr Food Res; 2008 Jun; 52 Suppl 1():S103-27. PubMed ID: 18496811
[TBL] [Abstract][Full Text] [Related]
7. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3.
Chendil D; Ranga RS; Meigooni D; Sathishkumar S; Ahmed MM
Oncogene; 2004 Feb; 23(8):1599-607. PubMed ID: 14985701
[TBL] [Abstract][Full Text] [Related]
8. Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products.
Kunnumakkara AB; Diagaradjane P; Guha S; Deorukhkar A; Shentu S; Aggarwal BB; Krishnan S
Clin Cancer Res; 2008 Apr; 14(7):2128-36. PubMed ID: 18381954
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets.
Aggarwal BB; Sung B
Trends Pharmacol Sci; 2009 Feb; 30(2):85-94. PubMed ID: 19110321
[TBL] [Abstract][Full Text] [Related]
10. Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies.
Epstein J; Sanderson IR; Macdonald TT
Br J Nutr; 2010 Jun; 103(11):1545-57. PubMed ID: 20100380
[TBL] [Abstract][Full Text] [Related]
11. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
[TBL] [Abstract][Full Text] [Related]
12. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins.
Kunnumakkara AB; Anand P; Aggarwal BB
Cancer Lett; 2008 Oct; 269(2):199-225. PubMed ID: 18479807
[TBL] [Abstract][Full Text] [Related]
13. Curcumin content of turmeric and curry powders.
Tayyem RF; Heath DD; Al-Delaimy WK; Rock CL
Nutr Cancer; 2006; 55(2):126-31. PubMed ID: 17044766
[TBL] [Abstract][Full Text] [Related]
14. Curcumin for chemoprevention of colon cancer.
Johnson JJ; Mukhtar H
Cancer Lett; 2007 Oct; 255(2):170-81. PubMed ID: 17448598
[TBL] [Abstract][Full Text] [Related]
15. Multitargeting by turmeric, the golden spice: From kitchen to clinic.
Gupta SC; Sung B; Kim JH; Prasad S; Li S; Aggarwal BB
Mol Nutr Food Res; 2013 Sep; 57(9):1510-28. PubMed ID: 22887802
[TBL] [Abstract][Full Text] [Related]
16. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials.
Shehzad A; Wahid F; Lee YS
Arch Pharm (Weinheim); 2010 Sep; 343(9):489-99. PubMed ID: 20726007
[TBL] [Abstract][Full Text] [Related]
17. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors.
Dhandapani KM; Mahesh VB; Brann DW
J Neurochem; 2007 Jul; 102(2):522-38. PubMed ID: 17596214
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of curcumin on tumorigenesis in mice.
Huang MT; Newmark HL; Frenkel K
J Cell Biochem Suppl; 1997; 27():26-34. PubMed ID: 9591190
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin.
Kim JH; Xu C; Keum YS; Reddy B; Conney A; Kong AN
Carcinogenesis; 2006 Mar; 27(3):475-82. PubMed ID: 16299382
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice.
Huang MT; Lou YR; Ma W; Newmark HL; Reuhl KR; Conney AH
Cancer Res; 1994 Nov; 54(22):5841-7. PubMed ID: 7954412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
